Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Grab Holdings Ltd. (GRAB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Grab Holdings Ltd. — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $70.39 (market cap $30.93B), while Grab Holdings Ltd. trades at $2.96 (market cap $11.91B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 2.6× Grab Holdings Ltd.'s market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while Grab Holdings Ltd. pays none. Which is the better fit depends on your goals.
| GEHC | GRAB | |
|---|---|---|
Market Cap | $30.93B | $11.91B |
Volume | 5,033,451 | 62,622,940 |
Sector | Health | Technology |
52-Week High | $88.16 | $6.12 |
52-Week Low | $59.48 | $2.80 |
Enterprise Value | $39.39B | $7.64B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 94 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
GRAB Holdings Limited (GRAB) trades at $2.98, down 5.4% on the day, amid a bearish technical signal. Fundamentally, the company shows strong improvement with revenue growing to $3.37B in 2025 and net income turning positive at $268M. Recent Q2 2026 earnings beat expectations with EPS of $0.06 versus $0.05 expected. The company is expanding aggressively with a $1.49B acquisition of a majority stake in Atome Financial, targeting financial services growth.
The outlook is mixed: strong analyst support (91.67% buy ratings) and insider buying signal confidence, but technical weakness and high capital expenditure for acquisitions pose near-term risks. Profitability trends are positive, yet competitive pressures in Southeast Asia and integration challenges from recent M&A are key watchpoints for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Grab Holdings Ltd.
Grab Holdings Limited operates as a holding company. The Company, through its subsidiaries, develops delivery management, mobility, financial services, and enterprise software solutions. Grab Holdings serves customers worldwide.
Read more on GRAB →
